Japan’s Drug Distribution Crisis: Pharma Urges Govt To Reform Pricing System

Low Prices Seen Part Of Wider Problem

 
• By Lisa Takagi
  
Japanese pharmaceutical firms and associations have urged the government to reform the pricing review system in recent discussion
Almost 1000 generics have seen production halted • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Policy & Regulation